Sage Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
715
+114
| +19% | +$50.7K | 0.08% | 118 |
|
|
2025
Q1 | $291K | Buy |
601
+48
| +9% | +$23.3K | 0.08% | 121 |
|
|
2024
Q4 | $223K | Hold |
553
| – | – | 0.06% | 130 |
|
|
2024
Q3 | $257K | Hold |
553
| – | – | 0.07% | 125 |
|
|
2024
Q2 | $259K | Buy |
553
+30
| +6% | +$14.1K | 0.07% | 126 |
|
|
2024
Q1 | $219K | Hold |
523
| – | – | 0.06% | 130 |
|
|
2023
Q4 | $213K | Buy |
+523
| New | +$213K | 0.07% | 126 |
|